echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > What is the charm of collecting wrists in health reform?

    What is the charm of collecting wrists in health reform?

    • Last Update: 2020-07-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    How can the life of the text/code million be like snow, quietly come, leisurely meltinglife, should be snow-covered river flows, pentium out of a magnificent journey ..It's a feelingcollection for the industry, like the weather changes dramatically, heavy snow is bound to have markswhen the snow is booming, we explore the present and future of medical reformis the collection of which to fight, with the fastest efficiency to alleviate medical asymmetryas a researcher, this experience is my trouble and understanding when I look at the literatureto find answers to a specific research question, often have to read a large number of reference symns, its efficiency is very low, the effect is not necessarily goodwe see centralized procurement, belt procurement, generally with the target, the original on an indication disorder do not know which drug outstanding, good use, by collection such a promotion, hospitals, clinical lying procurement, use tasks, patients to some extent "sit and enjoy it", in the coming era of health, this is a large-scale professional "cloud"the second is to mobilize pharmaceutical enterprises from entropy chaos to "you die I live."in the gradual promotion of the size of the collection activities, there have been pharmaceutical enterprises as a wall view, not together that livelybut just as many chemical pharmaceutical enterprises mistakenly grasp China's determination to promote consistency evaluation work into the normal and into a passive, the present and in the future I am afraid no one is willing to "retreat from the endless, dynamic normal collection", the so-called "fight without breaking" not "attack it."in the or grand, or micro-market situation, enterprises and competitors, strategic buyers, between each other's sword, bright lightsthe pharmaceutical industry, turnto the medical industryis that the biggest beneficiaries of collection are older persons and ageingif there is no collection of activities to organize drug price reduction, found that the industry mature competition for the development of social security of the great back-feeding, we can not imagine: the outpatient hypertension diabetes two diseases of drugs into the residents of basic medical insurance, the grand policy of financial affordability, future sustainabilityis with the "4 plus 7" and other collection policies and results to do endorsement, we in the pharmaceutical market in the old price form of a waste to the pharmaceutical industry in the end, and continue to focus on the interests of the people, efficient, have the strength of special groups, specific diseases to do the treatment of the moderate tilt protection fourth is the collection of not afraid of too many unreasonable phenomenon, force normal someone in the "4 plus 7" belt after the purchase comments: there are thousands of non-collection, tape procurement varieties, who to manage? When will you take care of it? Some people in the county and city supplies collection was called off after the comments: these low-volume, low-level, limited effective collection is not a form of walk? Is price preservation required to be collected? On the one hand, we have confidence and patience in the collection, on the other hand, we have great expectations for the normal, dynamic and full coverage of the collection pan-collection also bring stakes, will be linked network procurement and price-limiting competition (recruitment, negotiation) combined to real competition to de-administration Five is the combination of collection efficiency and industrial preservation to promote domestic substitution several rounds of state-level volume procurement, mainly to national pharmaceutical enterprises winning the bid, procurement results in the clinical floor release volume, grasping the appearance of a "patent cliff" effect, after a period of time singing the decline of generic drugs "money way", a number of promising domestic pharmaceutical enterprises to rush to the first imitation of counterfeit drugs, biologically similar drugs and even innovative drugs in supplies, domestic substitution is stronger from the results, we see that the industry has the natural reflex ability to break the old arm for a new life, but also see the policy reform rationally adhere to the comprehensive, phased, pilot promotion, as far as possible so that the supply and demand side are adapted Six is the logical and methodological evolution of collection from medicine to consumables several rounds of drug collection, mainly recruitment, volume price-linked, advertised after the absolute price level or reduction of more than 50% and so on but supplies some representative local pilot (such as Fujian) shows a number of rounds of quotations, a number of winning, sharing belt volume and other characteristics to adapt to market conditions, this model once confirmed the effect of phase-down price reduction, it is suitable for rapid application to almost all supplies classification from the requirement of single-family or oligarchs to bid at very low prices, to the requirement of a wide range of varieties are required to show the decline in stages, from the administrative characteristics of deciding which varieties, the expected adjustment range to the market competition quotation, to all competitors to put forward a basic reduction requirements thus in the collection tools to achieve dynamic start-up, which not only adapts to the variety of consumables, the status quo of the connotation grade gap, the category design more enlightened selection rules, to the scale of different, different stages of enterprises to the same competitive share of the opportunity, may also become simple, better than drug price reform 7 is the result of collecting results to provide obvious visible help to comprehensive medical reform we think: the health care industry is relatively simple than the medical industry management, the pharmaceutical industry has a certain base and integrate into the global division of labor, but also easily adapted to the medical industry, soon see the wise, see the sage and introspection the current reform of payment methods and pay distribution in the medical industry is a difficult matter collection results hit a part of the gold sales, will continue to sweep, the medical industry pay distribution reform of the necessary start time greatly ahead of time, but also according to the disease diagnosis related to payment and other payment methods of the smooth entry into the market, for the hospital through independent procurement (such as gradually liberalizing the second bargaining) to find balance to stay space to create a good situation deeper chain reaction, will also be transmitted to the multi-level medical security system ecological construction has been stuck in the commercial medical insurance, mutual medical plan, etc to see the results of collection, medical control costs will dare to the basic health insurance supplementary role bigger and stronger, which is more open than simple drug insurance cooperation, much more brilliant with the help of medical reform, Internet big data, the popularity of big health culture, China's medical health insurance market must be effective 8 is the stage of the success of collection and the form conversion reflects the Chinese characteristics in the three medical linkage, Chinese characteristics is the main health insurance carrying a banner, the medical insurance team is a hard-fought team, on their own and the medical industry, medicine industry, insurance industry, a series of dysentery has a series of dysentery and the feelings of drawing a blueprint in our view, the current new crown epidemic prevention and control results, will do the heavy disease medical insurance and relief, the future of rare diseases and the elderly group treatment costs of consideration, in terms of implementation capacity and effect, the burden is different degrees of the collection of stage results and form conversion only with Chinese characteristics, can play a three-medical linkage of a mind, to the people's interests as the center, can take care of national medicine, supplies, health industrial structure upgrade and catch up with the window period, reflect the advantages of policy guidance, help, can seize the nose of cattle, to show strategic buyers will supply-side reform and people's livelihood security needs combined wisdom the form of collection to the market more peaceful rhythm, as well as the fierce global mobilization .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.